Bioprinting of Cell-Laden Hydrogels onto Titanium Alloy Surfaces to Produce a Bioactive Interface

Macromol Biosci. 2022 Jun;22(6):e2200071. doi: 10.1002/mabi.202200071. Epub 2022 Apr 11.

Abstract

The surface of metal implants serves as a powerful signaling cue for cells. Its properties play an essential role in stabilizing the bone-implant interface and facilitating the early osseointegration by encouraging bone deposition on the surface. However, effective strategies to deliver cells to the metal surfaces are yet to be explored. Here, a bioprinting process, called reactive jet impingement (ReJI), is used to deposit high concentrations (4 × 107 cells mL-1 ) of mesenchymal stromal cells (MSCs) within hydrogel matrices directly onto the titanium alloy surfaces that vary in surface roughness and morphology. In this proof-of-concept study, cell-hydrogel-metal systems are fabricated with the aim of enhancing bioactivity through delivering MSCs in hydrogels at the bone-implant interface. These results show that the high cell concentrations encourage quick cell-biomaterial interactions at the hydrogel-metal surface interface, and cell morphology is influenced by the surface type. Cells migrate from the hydrogels and deposit mineralized matrix rich in calcium and phosphorus on the titanium alloy surfaces. The authors demonstrate that ReJI bioprinting is a promising tool to deliver cells in a 3D environment before implantation that can be used when developing a new generation of medical devices for bone tissue engineering.

Keywords: bioactive interface; bioprinting; bone tissue engineering; bone-implant interface; cell-laden hydrogels; titanium alloy implants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alloys
  • Bioprinting* / methods
  • Hydrogels / pharmacology
  • Osseointegration
  • Titanium / pharmacology

Substances

  • Alloys
  • Hydrogels
  • Titanium